[The complex assessment of efficiency of therapeutic training in patients with type 2 diabetes mellitus and destructive pulmonary tuberculosis].
115 patients from 39 to 70 years old with type 2 diabetes mellitus (DM) and destructive pulmonary tuberculosis (PT) were included in the study. All patients received standard regimens of antituberculous therapy. At admission all patients were in state of decompensation of carbohydrate metabolism. Criteria of DM optimal metabolic control were determined individually subject to state of cognitive functions and life expectancy. Combined clinico-laboratory and roentgenologic examinations and special questioning were performed. The patients were divided into groups matched for social-demographic, clinical parameters and methods of metabolic disturbances correction. The main group patients took complex training of DM patients program adapted for PT patients. The modification of training was based on psychosocial and clinical features of these patients category. Primary course last 8 hours with following dynamic observation and correction in 1 and 3 months. The patients of comparison group did not take purposeful training. They received required information from medical specialists during examinations. The study demonstrated higher efficiency of combined treatment in patients of main group. Use of therapeutic training of DM and PT patients is reasonable as an integrated component in the system of combined medical aid to these patients category.
Mel'nikova
N V
NV
D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care / Q000379:methods*; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000379:methods*; D015397:Program Evaluation; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D007004:Hypoglycemic Agents